Celltrion’s Remsima SC Ready For Early 2020 Launch
Formal EU Approval Received For ‘Biobetter’ Subcutaneous Infliximab
Celltrion says it is ready to roll out its Remsima SC subcutaneous infliximab in Europe in the first quarter of 2020, after receiving a formal pan-European marketing authorization from the European Commission.
